期刊文献+

美沙拉嗪与枯草杆菌二联活菌肠溶胶囊联合治疗溃疡性结肠炎的疗效分析 被引量:4

Clinical Analysis of The Beauty of Salad with Live Combined Bacillus Subtilis two Bacteria Enteric Capsules in the Treatment of Ulcerative Colitis
下载PDF
导出
摘要 目的探讨美沙拉嗪联合枯草杆菌二联活茵肠溶胶囊治疗溃疡性结肠炎的疗效。方法回顾性分析2014年8月至2015年5月我院收治的溃疡性结肠炎患者80例,随机分为治疗组(40例)和对照组(40例),对照组采取美沙拉嗪治疗,治疗组在对照组基础上采用枯草杆菌二联活菌肠溶胶囊治疗,分析两组患者的治疗效果。结果观察组治疗总有效率显著高于对照组(P<0.05),治疗期间患者无严重不良反应。两组差异有统计学意义(P<0.05)。结论美沙拉嗪联合枯草杆菌二联活菌肠溶胶囊在溃疡性结肠炎治疗中有显著疗效,不仅改善患者临床症状,而且减少复发,值得临床推广应用。 Objective To investigate the effect of combined treatment of salad beauty live combined Bacillus subtilis two Yin capsules in the treatment of ulcerative colitis. Methods From May 2015 to August 2014, 80 patients with ulcerative colitis were randomly divided into treatment group (40 cases) and control group (40 cases). The treatment group was treated with Bacillus subtilis two. Results The total effective rate of observation group was significantly higher than that of the control group (P〈0.05), the patients had no serious adverse reactions during the treatment. The difference between the two groups was statistically significant (P〈0.05). Conclusion Mesalazine combined with Bacillus subtilis bivalent live bacteria enteric coated capsules in the treatment of ulcerative colitis has remarkable curative effect, not only improve the clinical symptoms of the patients, and reduce the recurrence. It is worthy of clinical application.
作者 席智文
出处 《中国医药指南》 2016年第10期18-19,共2页 Guide of China Medicine
关键词 美沙拉嗪 枯草杆菌二联活菌肠溶胶囊 溃疡性结肠炎 Beauty salad Combined Bacillus subtilis two viable capsules Ulcerative colitis
  • 相关文献

参考文献11

二级参考文献98

  • 1杜艳茹,张纨,王延峰,刘玉来,孟建华,李佃贵.李佃贵从浊毒论治溃疡性结肠炎[J].上海中医药杂志,2009,43(2):7-8. 被引量:43
  • 2Petros Zezos,Georgia Papaioannou,Nikolaos Nikolaidis,Themistoclis Vasiliadis,Olga Giouleme,Nikolaos Evgenidis.Hyperhomocysteinemia in ulcerative colitis is related to folate levels[J].World Journal of Gastroenterology,2005,11(38):6038-6042. 被引量:2
  • 3顾培青.路广晁治疗溃疡性结肠炎经验[J].山东中医杂志,2006,25(10):709-710. 被引量:19
  • 4刘晏,张萍,项平,余莉芳.“肠愈宁方”治疗溃疡性结肠炎40例[J].江苏中医药,2007,39(4):25-26. 被引量:5
  • 5Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 Suppl 5:V1-16.
  • 6Okamoto R, Watanabe M. Molecular and clinicalbasis for the regeneration of human gastrointestinal epithelia, J Gastroentero12004; 39:1-6.
  • 7Mitsuyama K, Andoh A, Masuda J, Yamasaki H, Kuwaki K, Takedatsu H, Seki R, Nishida H, Tsuruta O, Sata M. Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis. Ther Apher Dial 2008; 12:271-277.
  • 8Lanzoni G, Roda G, Belluzzi A, Roda E, Bagnara GP. Inflammatory bowel disease: Moving toward a stem ceil-based therapy. World I Gastroenterol 2008; 14:4616-4626.
  • 9Hayashi Y, Tsuji S, Tsujii M, Nishida T, Ishii S, Ii- jima H, Nakamura T, Eguchi H, Miyoshi E, Hayashi N, Kawano 5. Topical implantation of mesenchymal stem cells has beneficial effects on healing of experi- mental colitis in rats. l Pharmacol Exp Ther 2008; 326: 523-531.
  • 10Rutgeerts P, Van Assche G, Vermeire S. Review article: Infliximab therapy for inflammatory bowel disease--seven years on. Aliment Pharmacol Ther 2006; 23:451-463.

共引文献1161

同被引文献25

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部